Skip to content

Dry eye and changes in orbicularis oculi muscle function after extraocular muscle botulinum toxin injection

Dry eye and changes in orbicularis oculi muscle function after extraocular muscle botulinum toxin injection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111515
Enrollment
Unknown
Registered
2025-10-31
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strabismus

Interventions

Medial rectus muscle group (Transconjunctival injection of Botulinum Toxin Type A into the medial rectus muscle.):None
Lateral rectus muscle group (Transconjunctival injection of Botulinum Toxin Type A into the lateral rectus muscle.):None
Inferior oblique muscle group (Botulinum Toxin Type A is injected into the inferior oblique muscle through a conjunctival incision.):None

Sponsors

Eye Hospital, WMU
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1 Age: 18-65 years old 2 Angle of strabismus > 10 PD 3 Patients diagnosed with "paralytic strabismus" scheduled to undergo "extraocular muscle botulinum toxin injection" 4 Commitment to complete postoperative follow-ups as planned

Exclusion criteria

Exclusion criteria: 1 History of previous strabismus surgery or extraocular muscle botulinum toxin injection 2 History of other ocular surgeries 3 Ptosis or other eyelid anatomical abnormalities 4 Facial nerve paralysis 5 Systemic diseases such as myasthenia gravis or related conditions

Design outcomes

Primary

MeasureTime frame
Tear meniscus height;LipiView;Tear film lipid layer thickness;

Secondary

MeasureTime frame
Ocular alignment;Dry eye subjective symptom score ;Blink frequency;Incomplete blink ratio;Palpebral fissure height;

Countries

China

Contacts

Public ContactZhiqiang Xu

Eye Hospital, Wenzhou Medical University

1758137988@qq.com+86 577 8806 8862

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026